{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CRC", "ErbB signaling pathway", "FoxO signaling pathway", "Herba Patriniae", "Patrinia heterophylla", "colorectal cancer", "network pharmacology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34641576", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "15"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "05"}], "Language": ["eng"], "ELocationID": ["6032", "10.3390/molecules26196032"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "19", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "05"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Integrated Network Pharmacology Analysis and <i>In Vitro</i> Validation Revealed the Potential Active Components and Underlying Mechanistic Pathways of Herba Patriniae in Colorectal Cancer.", "Abstract": {"AbstractText": ["Herba Patriniae (HP) are medicinal plants commonly used in colorectal cancer (CRC) patients. In this study, network pharmacology was used to predict the active components and key signaling pathways of HP in CRC. <i>Patrinia heterophylla</i>, one type of HP, was chosen for validation of the network pharmacology analysis. The phytochemical profile of <i>Patrinia heterophylla</i> water extract (PHW) was determined by UHPLC-MS. MTT, RT-PCR, and Western blot assays were performed to evaluate the bioactivities of PHW in colon cancer cells. Results showed that 15 potentially active components of HP interacted with 28 putative targets of CRC in the compound-target network, of which asperglaucide had the highest degree. Furthermore, the ErbB signaling pathway was identified as the pathway mediated by HP with the most potential against CRC. Both RT-PCR and Western blot results showed that PHW significantly downregulated the mRNA and protein levels of EGFR, PI3K, and AKT in HCT116 cells. Asperglaucide, present in PHW, exhibited an anti-migratory effect in HCT116 cells, suggesting that it could be an active component of PHW in CRC treatment. In conclusion, this study has provided the first scientific evidence to support the use of PHW in CRC and paved the way for further research into the underlying mechanisms of PHW against CRC."]}, "AuthorList": [{"Identifier": ["0000-0002-9986-7362"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Yang", "ForeName": "Huihai", "Initials": "H"}, {"Identifier": ["0000-0002-2764-2113"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Cheung", "ForeName": "Man-Kit", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Yue", "ForeName": "Grace Gar-Lee", "Initials": "GG"}, {"Identifier": ["0000-0002-0195-4688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Leung", "ForeName": "Ping-Chung", "Initials": "PC"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Wong", "ForeName": "Chun-Kwok", "Initials": "CK"}, {"Identifier": ["0000-0002-7409-1270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Lau", "ForeName": "Clara Bik-San", "Initials": "CB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Dipeptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "FOXO1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Forkhead Box Protein O1"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "56121-42-7", "NameOfSubstance": "N-benzoylphenylalanylphenylalinol acetate"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "EGFR protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Adenocarcinoma"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dipeptides"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["metabolism"], "DescriptorName": "ErbB Receptors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Forkhead Box Protein O1"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["chemistry"], "DescriptorName": "Patrinia"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare that they have no conflicts of interest to disclose."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7\u201330. doi: 10.3322/caac.21590.", "ArticleIdList": ["10.3322/caac.21590", "31912902"]}, {"Citation": "Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467\u20131480. doi: 10.1016/S0140-6736(19)32319-0.", "ArticleIdList": ["10.1016/S0140-6736(19)32319-0", "31631858"]}, {"Citation": "Marmol I., Sanchez-de-Diego C., Pradilla Dieste A., Cerrada E., Rodriguez Yoldi M.J. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int. J. Mol. Sci. 2017;18:197. doi: 10.3390/ijms18010197.", "ArticleIdList": ["10.3390/ijms18010197", "PMC5297828", "28106826"]}, {"Citation": "Rennoll S., Yochum G. Regulation of MYC gene expression by aberrant Wnt/\u03b2-catenin signaling in colorectal cancer. World J. Biol. Chem. 2015;6:290\u2013300. doi: 10.4331/wjbc.v6.i4.290.", "ArticleIdList": ["10.4331/wjbc.v6.i4.290", "PMC4657124", "26629312"]}, {"Citation": "Herzig D.O., Tsikitis V.L. Molecular markers for colon diagnosis, prognosis and targeted therapy. J. Surg. Oncol. 2015;111:96\u2013102. doi: 10.1002/jso.23806.", "ArticleIdList": ["10.1002/jso.23806", "25297801"]}, {"Citation": "Gong L., Zou W., Zheng K., Shi B., Liu M. The Herba Patriniae (Caprifoliaceae): A review on traditional uses, phytochemistry, pharmacology and quality control. J. Ethnopharmacol. 2021;265:113264. doi: 10.1016/j.jep.2020.113264.", "ArticleIdList": ["10.1016/j.jep.2020.113264", "PMC7443212", "32846192"]}, {"Citation": "He X., Luan F., Zhao Z., Ning N., Li M., Jin L., Chang Y., Zhang Q., Wu N., Huang L. The genus Patrinia: A review of traditional uses, phytochemical and pharmacological studies. Am. J. Chin. Med. 2017;45:637\u2013666. doi: 10.1142/S0192415X17500379.", "ArticleIdList": ["10.1142/S0192415X17500379", "28595500"]}, {"Citation": "Zhang M., Sun G., Shen A., Liu L., Ding J., Peng J. Patrinia scabiosaefolia inhibits the proliferation of colorectal cancer in vitro and in vivo via G1/S cell cycle arrest. Oncol. Rep. 2015;33:856\u2013860. doi: 10.3892/or.2014.3663.", "ArticleIdList": ["10.3892/or.2014.3663", "25500894"]}, {"Citation": "Liu L., Shen A., Chen Y., Wei L., Lin J., Sferra T.J., Hong Z., Peng J. Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer. Oncol. Rep. 2013;30:897\u2013903. doi: 10.3892/or.2013.2528.", "ArticleIdList": ["10.3892/or.2013.2528", "23754194"]}, {"Citation": "Chen L., Liu L., Ye L., Shen A., Chen Y., Sferra T.J., Peng J. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis. Oncol. Rep. 2013;30:1439\u20131443. doi: 10.3892/or.2013.2582.", "ArticleIdList": ["10.3892/or.2013.2582", "23820929"]}, {"Citation": "Huang S., Liu W., Huang Y., Shen A., Liu L., Peng J. Patrinia scabiosaefolia inhibits growth of 5-FU-resistant colorectal carcinoma cells via induction of apoptosis and suppression of AKT pathway. Chin. J. Integr. Med. 2019;25:116\u2013121. doi: 10.1007/s11655-018-3002-6.", "ArticleIdList": ["10.1007/s11655-018-3002-6", "29948597"]}, {"Citation": "Yanmei Z., Xunlong Z., Jihua W., Liang H. Rapid analysis and identification of the main constituents in Patrinia scabiosaefolia Fisch. by UPLC/Q-TOF-MS/MS. Acta Chromatogr. 2017;29:267\u2013277."}, {"Citation": "Wang L., Li Z., Zhao X., Liu W., Liu Y., Yang J., Li X., Fan X., Cheng Y. A network study of Chinese medicine Xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway. Evid. Based Complement. Altern. Med. 2013;2013:652373. doi: 10.1155/2013/652373.", "ArticleIdList": ["10.1155/2013/652373", "PMC3766588", "24058375"]}, {"Citation": "Zhang R., Zhu X., Bai H., Ning K. Network pharmacology databases for traditional Chinese medicine: Review and assessment. Front. Pharmacol. 2019;10:123. doi: 10.3389/fphar.2019.00123.", "ArticleIdList": ["10.3389/fphar.2019.00123", "PMC6393382", "30846939"]}, {"Citation": "Yang B., Wang N., Wang S., Li X., Zheng Y., Li M., Song J., Zhang F., Mei W., Lin Y., et al. Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis. Biomed. Pharmacother. 2019;112:108607. doi: 10.1016/j.biopha.2019.108607.", "ArticleIdList": ["10.1016/j.biopha.2019.108607", "30784915"]}, {"Citation": "Huang S., Zhang Z., Li W., Kong F., Huang J., Mao D., Peng W., Zhang S. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Zuojinwan for treating colorectal cancer. Drug Des. Dev. Ther. 2020;14:2725\u20132740. doi: 10.2147/DDDT.S250991.", "ArticleIdList": ["10.2147/DDDT.S250991", "PMC7369379", "32764874"]}, {"Citation": "Gu L., Lu J., Li Q., Wu N., Zhang L., Li H., Xing W., Zhang X. A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer\u2019s disease and experimental validation. J. Ethnopharmacol. 2020;251:112488. doi: 10.1016/j.jep.2019.112488.", "ArticleIdList": ["10.1016/j.jep.2019.112488", "31866509"]}, {"Citation": "Kengo I., Yasuyuki A., Sumiko T., Maki N., Tomofumi U., Toru O., Saburo K., Naoki S. Aurantiamide acetate, a selective cathepsin inhibitor, produced by Aspergillus penicilloides. Biosci. Biotechnol. Biochem. 2001;65:1195\u20131197.", "ArticleIdList": ["11440138"]}, {"Citation": "Hopkins A.L. Network pharmacology. Nat. Biotechnol. 2007;25:1110\u20131111. doi: 10.1038/nbt1007-1110.", "ArticleIdList": ["10.1038/nbt1007-1110", "17921993"]}, {"Citation": "Lyu M., Zhou Z., Wang X., Lv H., Wang M., Pan G., Wang Y., Fan G., Gao X., Feng Y., et al. Network pharmacology-guided development of a novel integrative regimen to prevent acute graft-vs.-host disease. Front. Pharmacol. 2018;9:1440. doi: 10.3389/fphar.2018.01440.", "ArticleIdList": ["10.3389/fphar.2018.01440", "PMC6300759", "30618740"]}, {"Citation": "Huttlin E.L., Bruckner R.J., Paulo J.A., Cannon J.R., Ting L., Baltier K., Colby G., Gebreab F., Gygi M.P., Parzen H., et al. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545:505\u2013509. doi: 10.1038/nature22366.", "ArticleIdList": ["10.1038/nature22366", "PMC5531611", "28514442"]}, {"Citation": "Ligresti G., Militello L., Steelman L.S., Cavallaro A., Basile F., Nicoletti F., Stivala F., McCubrey J.A., Libra M. PIK3CA mutations in human solid tumors. Cell Cycle. 2009;8:1352\u20131358. doi: 10.4161/cc.8.9.8255.", "ArticleIdList": ["10.4161/cc.8.9.8255", "PMC3781181", "19305151"]}, {"Citation": "Sahlberg S.H., Mortensen A.C., Hagl\u00f6f J., Engskog M.K.R., Arvidsson T., Pettersson C., Glimelius B., Stenerl\u00f6w B., Nestor M. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells. Int. J. Oncol. 2017;50:5\u201314. doi: 10.3892/ijo.2016.3771.", "ArticleIdList": ["10.3892/ijo.2016.3771", "PMC5182003", "27878243"]}, {"Citation": "Slattery M.L., Lundgreen A., Wolff R.K. MAP kinase genes and colon and rectal cancer. Carcinogenesis. 2012;33:2398\u20132408. doi: 10.1093/carcin/bgs305.", "ArticleIdList": ["10.1093/carcin/bgs305", "PMC3510742", "23027623"]}, {"Citation": "Ven\u00e8 R., Costa D., Augugliaro R., Carlone S., Scabini S., Pattacini G.C., Boggio M., Zupo S., Grillo F., Mastracci L., et al. Evaluation of glycosylated PTGS2 in colorectal cancer for NSAIDS-based adjuvant therapy. Cell. 2020;9:683. doi: 10.3390/cells9030683.", "ArticleIdList": ["10.3390/cells9030683", "PMC7140631", "32168749"]}, {"Citation": "Loree J.M., Bailey A.M., Johnson A.M., Yu Y., Wu W., Bristow C.A., Davis J.S., Shaw K.R., Broaddus R., Banks K.C., et al. Molecular landscape of ERBB2/ERBB3 mutated colorectal cancer. J. Natl. Cancer Inst. 2018;110:1409\u20131417. doi: 10.1093/jnci/djy067.", "ArticleIdList": ["10.1093/jnci/djy067", "PMC6292791", "29718453"]}, {"Citation": "Appert-Collin A., Hubert P., Cr\u00e9mel G., Bennasroune A. Role of ErbB receptors in cancer cell migration and invasion. Front. Pharmacol. 2015;6:283. doi: 10.3389/fphar.2015.00283.", "ArticleIdList": ["10.3389/fphar.2015.00283", "PMC4657385", "26635612"]}, {"Citation": "Hirsh V. Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: Optimal sequential therapy with EGFR tyrosine kinase inhibitors. Ther. Adv. Med. Oncol. 2018;10:1\u201312. doi: 10.1177/1758834017753338.", "ArticleIdList": ["10.1177/1758834017753338", "PMC5784552", "29383041"]}, {"Citation": "Wee P., Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancer. 2017;9:52. doi: 10.3390/cancers9050052.", "ArticleIdList": ["10.3390/cancers9050052", "PMC5447962", "28513565"]}, {"Citation": "Cairns J., Fridley B.L., Jenkins G.D., Zhuang Y., Yu J., wang L. Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation. EMBO Rep. 2018;19:e44767. doi: 10.15252/embr.201744767.", "ArticleIdList": ["10.15252/embr.201744767", "PMC5835844", "29335246"]}, {"Citation": "Park H.K., Kim I.H., Kim J., Nam T.J. Induction of apoptosis and the regulation of ErbB signaling by laminarin in HT-29 human colon cancer cells. Int. J. Mol. Med. 2013;32:291\u2013295. doi: 10.3892/ijmm.2013.1409.", "ArticleIdList": ["10.3892/ijmm.2013.1409", "PMC3776715", "23739740"]}, {"Citation": "Lv Q., Xia Q., Li J., Wang Z. Allicin suppresses growth and metastasis of gastric carcinoma: The key role of microRNA-383\u20135p-mediated inhibition of ERBB4 signaling. Biosci. Biotechnol. Biochem. 2020;84:1997\u20132004. doi: 10.1080/09168451.2020.1780903.", "ArticleIdList": ["10.1080/09168451.2020.1780903", "32597323"]}, {"Citation": "Farhan M., Wang H., Gaur U., Little P.J., Xu J., Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int. J. Biol. Sci. 2017;13:815\u2013827. doi: 10.7150/ijbs.20052.", "ArticleIdList": ["10.7150/ijbs.20052", "PMC5555100", "28808415"]}, {"Citation": "Poto\u010dnjak I., \u0160imi\u0107 L., Gobin I., Vukeli\u0107 I., Domitrovi\u0107 R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol. In Vitro. 2020;66:104852. doi: 10.1016/j.tiv.2020.104852.", "ArticleIdList": ["10.1016/j.tiv.2020.104852", "32268164"]}, {"Citation": "Bahuguna A., Khan I., Bajpai V.K., Kang S.C. MTT assay to evaluate the cytotoxic potential of a drug. Bangladesh J. Pharmacol. 2017;12:115\u2013118. doi: 10.3329/bjp.v12i2.30892.", "ArticleIdList": ["10.3329/bjp.v12i2.30892"]}, {"Citation": "Wang H.-Q., Zhu Y.-X., Liu Y.-N., Wang R.-L., Shu-Fang W. Rapid discovery and identification of the anti-inflammatory constituents in Zhi-Shi-Zhi-Zi-Chi-Tang. Chin. J. Natl. Med. 2019;17:308\u2013320. doi: 10.1016/S1875-5364(19)30035-4.", "ArticleIdList": ["10.1016/S1875-5364(19)30035-4", "31076135"]}, {"Citation": "Zhou B., Yang Z., Feng Q., Liang X., Li J., Zanin M., Jiang Z., Zhong N. Aurantiamide acetate from Baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-\u03baB signaling pathway in Influenza A virus-infected cells. J. Ethnopharmacol. 2017;199:60\u201367. doi: 10.1016/j.jep.2017.01.038.", "ArticleIdList": ["10.1016/j.jep.2017.01.038", "28119097"]}, {"Citation": "Yang Y., Zhang L., Yang B., Tian J., Zhang L. Aurantiamide acetate suppresses the growth of malignant gliomas in vitro and in vivo by inhibiting autophagic flux. J. Cell. Mol. Med. 2015;19:1055\u20131064. doi: 10.1111/jcmm.12498.", "ArticleIdList": ["10.1111/jcmm.12498", "PMC4420607", "25704599"]}, {"Citation": "Ruan H., Hao S., Young P., Zhang H. Targeting cathepsin B for cancer therapies. Horiz. Cancer Res. 2015;56:23\u201340.", "ArticleIdList": ["PMC4662557", "26623174"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B., et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res. 2019;47:D1102\u2013D1109. doi: 10.1093/nar/gky1033.", "ArticleIdList": ["10.1093/nar/gky1033", "PMC6324075", "30371825"]}, {"Citation": "Gfeller D., Grosdidier A., Wirth M., Daina A., Michielin O., Zoete V. SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42:W32\u2013W38. doi: 10.1093/nar/gku293.", "ArticleIdList": ["10.1093/nar/gku293", "PMC4086140", "24792161"]}, {"Citation": "Wang Y., Zhang S., Li F., Zhou Y., Zhang Y., Wang Z., Zhang R., Zhu J., Ren Y., Tan Y., et al. Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2020;48:D1031\u2013D1041. doi: 10.1093/nar/gkz981.", "ArticleIdList": ["10.1093/nar/gkz981", "PMC7145558", "31691823"]}, {"Citation": "Amberger J., Bocchini C., Scott A.F., Hamosh A. OMIM.org: Leveraging knowledge across phenotype\u2013gene relationships. Nucleic Acids Res. 2019;47:D1038\u2013D1043. doi: 10.1093/nar/gky1151.", "ArticleIdList": ["10.1093/nar/gky1151", "PMC6323937", "30445645"]}, {"Citation": "Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u2013D613. doi: 10.1093/nar/gky1131.", "ArticleIdList": ["10.1093/nar/gky1131", "PMC6323986", "30476243"]}, {"Citation": "Assenov Y., Ram\u00edrez F., Schelhorn S.-E., Lengauer T., Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24:282\u2013284. doi: 10.1093/bioinformatics/btm554.", "ArticleIdList": ["10.1093/bioinformatics/btm554", "18006545"]}, {"Citation": "Wang: Y., Liu Z., Li C., Li D., Ouyang Y., Yu J., Guo S., He F., Wang W. Drug target prediction based on the herbs components: The study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease. Evid. Based Complement. Altern. Med. 2012;2012:698531. doi: 10.1155/2012/698531.", "ArticleIdList": ["10.1155/2012/698531", "PMC3310183", "22474514"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "10"}, {"Year": "2021", "Month": "9", "Day": "29"}, {"Year": "2021", "Month": "10", "Day": "1"}, {"Year": "2021", "Month": "10", "Day": "13", "Hour": "1", "Minute": "14"}, {"Year": "2021", "Month": "10", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["34641576", "PMC8513027", "10.3390/molecules26196032", "molecules26196032"]}}], "PubmedBookArticle": []}